1. Deal Surge & Balance Sheet Strength
-
Doubling of Deal Volumes: Annual Mergers and Acquisitions (M&A) deal volumes by Indian companies have more than doubled since fiscal 2017, driven by corporate efforts to scale faster, access new markets, and acquire tech capabilities.
-
Healthier Balance Sheets: Increased M&A activity is backed by lower corporate leverage and prudent funding. The median Net Debt-to-EBITDA for CRISIL-rated corporates declined to ~1.3x in FY26, down from ~2.4x in FY17.
-
Organic CapEx Moderation: Companies are prioritizing strategic acquisitions alongside controlled organic capital expenditure (CapEx) to achieve faster time-to-market.
2. Sector-Specific Acquisition Motives
-
Pharma, Tech, Healthcare, AI & Consumer: Primary drivers are acquiring technology, technical talent, proprietary software, and intellectual property (IP).
-
Cement & Metals: Key drivers are market consolidation and shortening capacity expansion timelines—reducing ramp-up times from 4–6 years (greenfield) down to 1–3 years (brownfield/acquisition).
3. Performance & Credit Rating Outcomes
A. Success Rate & Operational Gains
-
Expectation Match: Two-thirds (~67%) of the 100 large debt-funded acquisitions reviewed by CRISIL broadly met initial business expectations.
-
Scale & Margin Synergies: Successful acquirers achieved a 20% to 80% expansion in operational scale within 1 to 2 years, with operating margin improvements taking effect by Year 2.
-
Positive Credit Impact: Around 75% of credit ratings were reaffirmed or upgraded post-acquisition, and ~60% of acquiring firms deleveraged on or ahead of plan within two years.
B. Key Risks & Execution Pitfalls
For the one-third of acquisitions that fell short of expectations, CRISIL identified three major failure modes:
-
Integration Challenges: Accounted for ~50% of underperforming deals.
-
Regulatory Delays: Contributed to ~20% of delays and cost overruns.
-
Cross-Border Execution Issues: Represented ~20% of weaker outcomes.
